Axogen Inc vs Pinterest Inc — how do they compare? Axogen Inc trades at $49.66 (market cap $2.61B), while Pinterest Inc trades at $22.91 (market cap $13.45B). The key difference: Pinterest Inc is far larger — about 5.2× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | PINS | |
|---|---|---|
Market Cap | $2.61B | $13.45B |
Sector | Technology | Media |
52-Week High | $48.48 | $37.95 |
52-Week Low | $14.16 | $15.42 |
Enterprise Value | $2.52B | $13.37B |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $49.10, up 1.82% with strong technical momentum and bullish analyst sentiment. The stock shows robust revenue growth (23.1% in Q2 2026) and raised full-year guidance to $279 million, though profitability remains negative with a -13.36% net margin. Technical indicators show overbought RSI levels but strong moving average support, while institutional ownership and analyst consensus (84% buy ratings) signal confidence in the company's nerve care platform expansion.
The outlook remains positive given strong revenue momentum and regulatory advantages, but investors face execution risks from persistent losses and high valuation multiples. Upside potential exists toward the $54.33 consensus target if margin improvements materialize, though volatility may persist near current resistance levels.
Pinterest (PINS) trades at $22.93, down 5.91% over 24 hours, reflecting market disappointment despite strong Q2 2026 earnings beats. Revenue growth remains robust at 18% year-over-year, driven by AI-powered ads and record user growth to 640 million monthly active users. Technical indicators show a bullish moving average signal but neutral oscillators, with key support at $23. Recent news highlights a federal securities lawsuit investigation and CFO stock sales, adding volatility.
The outlook is mixed: solid fundamentals and a $28.69 analyst price target suggest upside, but competitive ad markets and lukewarm Q3 guidance pose risks. Investor sentiment is cautious despite bullish analyst consensus, with the stock's high P/E ratio of 69.85 requiring sustained growth to justify valuations. Key opportunities lie in international expansion and AI monetization, while legal and competitive pressures are headwinds.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →